Advisory Board August 10, 2022
The Inflation Reduction Act, which was passed by the Senate on Sunday, included several major health care reforms. Writing for STAT News, Rachel Cohrs reveals who the reforms will benefit most if the bill is signed into law.
Our take: 10 health policy topics—including drug pricing reform—to watch in 2022
Background
On Sunday, the Senate voted 51-50—with Vice President Kamala Harris casting the tiebreaking vote—to pass the Inflation Reduction Act, a $740 billion package.
If passed by the House of Representatives and signed by President Joe Biden, the Inflation Reduction Act will allow Medicare to negotiate certain prescription drug prices with pharmaceutical companies, saving the federal government roughly $288 billion over 10 years....